Probiotics and mucosal barrier in children

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 11, Issue 5, 2008, Pages 640-644

  Penna, Francisco J ^a,b   Péret, Luciano A ^a   Vieira, Leda Q ^b   Nicoli, Jacques R ^b  

^a Uveitis Section   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Gut microbiota; Infants; Mucosal barrier; Probiotic

Indexed keywords

PROBIOTIC AGENT;

ALLERGIC DISEASE; ATOPY; BIFIDOBACTERIUM; CELL CULTURE; CLINICAL TRIAL; GASTROINTESTINAL TRACT; HUMAN; INFECTION; INFLAMMATORY DISEASE; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS; MICROBIAL COLONIZATION; NECROTIZING ENTEROCOLITIS; NONHUMAN; REVIEW; ANIMAL; ANIMAL MODEL; ENTEROPATHY; MICROBIOLOGY; NEWBORN; PHYSIOLOGY;

ANIMALIA;

ANIMALS; CELLS, CULTURED; CLINICAL TRIALS AS TOPIC; HUMANS; INFANT, NEWBORN; INTESTINAL DISEASES; INTESTINAL MUCOSA; MODELS, ANIMAL; PROBIOTICS;

EID: 58149115518     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e32830a70ab     Document Type: Review

References (60)

1. Ismail AS, Hooper LV. Epithelial cells and their neighbors. IV. Bacterial contributions to intestinal epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol 2005; 289:G779-G784.
2. Neu J. Gastrointestinal maturation and implications for infant feeding. Early Human Dev 2007; 83:767-775.
3. Macpherson AJ, Geuking MB, McCoy KD. Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria. Immunology 2005; 115: 153-162.
4. Hooper LV. Bacterial contributions to mammalian gut development. Trends Microbiol 2004; 12:129-134.
5. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001; 292:1115-1118.
6. ScheppachW, Weiler F.The butyrate story:old wine innew bottles? Curr Opin Clin Nutr Metab Care 2006; 7:563-567.
7. Hamer HM, Jonkers D, Venema K, et al. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27:104-119.
8. Westerbeek EAM, van der Berg A, Lafeber HN, et al. The intestinal bacterial colonisation in preterm infants: a review of the literature. Clin Nutr 2006; 25:361-368.
9. Chen J, Cai W, Feng Y. Development of intestinal bifidobacteria and lactobacilli in breast-fed neonates. Clin Nutr 2007; 26:559-566.
10. Harmsen HJM, Wildeboer-VelooACM, RaangsGC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000; 30:61-67.
11. Bailey MT, Lubach GR, Coe Cl. Prenatal stress alters bacterial colonization of the gut in infant monkeys. J Pediatr Gastroenterol Nutr 2004; 38:414-421.
12. Bonnemaison E, Lanotte P, Cantagrel S, et al. Comparison of fecal flora following administration of two antibiotic protocols for suspected maternofetal infection. Biol Neonate 2003; 84:304-310.
13. Fasano A, Nataro JP. Intestinal epithelial tight junctions as targets for enteric bacteria-derived toxins. Adv Drug Deliv Rev 2004; 56:795-807.
14. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118:229-241.
15. Pull SL, Doherty JM, Mills JC, et al. Activated macrophages are an adaptative element to the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci USA 2005; 102:99-104.
16. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001; 121:580-591.
17. Hedin C, Whelan K, Lindsay JO. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Proc Nutr Soc 2007; 66:307-315.
18. FAO/WHO Report. Food and Agricultural Organization/World Health Organization Working Group. Guidelines for the Evaluation of Probiotics in Food, London, Ontario, Canada, 30 April and 1 May 2002.
19. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev 2004; 28:405-440.
20. Servin AL, Coconnier MH. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol 2003; 17:741-754.
21. Ezendam J, van Loveren H. Probiotics: immunomodulation and evaluation of safety and efficacy. Nutr Rev 2006; 64:1-14.
22. Brandao RL, Castro IM, Bambirra EA, et al. Intracellular signal triggered by cholera toxin in Saccharomyces boulardii and Saccharomyces cerevisiae. Appl Environ Microbiol 1998; 64:564-568.
23. Czerucka D, Dahan S, Mograbi B, et al. Saccharomyces boulardii preserves the barrier function and modulates the transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infect Immun 2000; 68:5998-6004.
24. Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003; 52:988-997.
25. Parassol N, Freitas M, Thoreux K, et al. Lactobacillus casei DN-114 001 inhibits the increase in paracellular permeability of enteropathogenic Escherichia coli-infected T84 cells. Res Microbiol 2005; 156:256-262.
26. Otte JM, Podolsky DK. Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 2006; 286:G613-G626.
27. Resta-Lenert S, Barrett KE. Probiotics and commensals reverse TNF-alpha and INF-gamma-induced dysfunction in human intestinal epithelial cells. Gastroenterology 2006; 130:731-746.
28. KoJS, Yang HR, Chang JY, Seo JK. Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukine-8 secretion induced by tumor necrosis factor-alpha. World J Gastroenterol 2007; 13:1962-1965.
29. Isolauri E, Kaila M, ArvolaT, et al. Diet during rotavirus enteritis affects jejunal permeability to macromolecules in suckling rats. Pediatr Res 1993; 33:548-553.
30. Isolauri E, Majamaa H, Arvola T, et al. Lactobacillus casei strain GG reverses intestinal permeability induced by cow's milk in suckling rats. Gastroenterology 1993; 105:1643-1650.
31. Mangell P, Nejdfors P, Wand M, et al. Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig Dis Sci 2002; 47:511-516.
32. Llopis M, Antolin M, Guarner F, et al. Mucosal colonization with Lactobacillus casei mitigates barrier injury induced by trinitrobenzene sulphonic acid. Gut 2005; 54:955-959.
33. Luyer MD, Buurman WA, Hadfoune M, et al. Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock. Infect Immun 2005; 73:3686-3692.
34. Qin HL, Shen TY, Gao ZG, et al. Effect of Lactobacillus on the gut microflora and barrier function of the rats with abdominal infection. World J Gastroenterol 2005; 11:2591-2596.
35. Heyman M, Terpend K, Menard S. Effects of specific lactic acid bacteria on the intestinal permeability to macromolecules and the inflammatory condition. Acta Paediatr 2005; 94 (Suppl):34-36.
36. Zareie M, Johnson-Henry K, Jury J, et al. Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006; 55:1553-1560.
37. Ewaschuk J, Endersby R, Thiel D, et al. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Hepatology 2007; 46:841-850.
38. Wu X, Vallance BA, Boyer L, et al. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. Am J Physiol Gastrointest Liver Physiol 2008; 294:G295-G306.
39. Rautava S. Potential uses of probiotics in the neonates. Semin Fetal Neonatal Med 2007; 12:45-53.
40. Schwiertz A, Gruhl B, Lobnitz M, et al. Development of the intestinal bacterial composition in hospitalisated preterm infants in comparison with breast-fed, full-term infants. Pediat Res 2003; 54:393-399.
41. Stratiki Z, Costalos C, Sevastiadou S, et al. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Human Dev 2007; 83:575-579.
42. Deshpande G, Rao S, Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007; 369:1614-1620.
43. Kalliomaki M, Kirjavainen P, Eerola E, et al. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001; 107:129-134.
44. Rosenfeld V, Benfeld E, Nielsen SD, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003; 111:389-395.
45. Rosenfeld V, Benfeld E, Valerius NH, et al. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr 2004; 145:612-616.
46. Kalliomǎki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001; 357:1076-1079.
47. Viljanen M, Savilahti E, Haahtela T, et al. Probiotics in the treatment of atopic/ dermatitis syndrome in infants: a double-blind placebo-controlled trial. Arch Dermatol 2006; 60:494-500.
48. Weston S, Halbert A, Richmond P, Prescott SL. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child 2005; 90:892-897.
49. Prescott SL, Dunstan JA, Hale J, et al. Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin Exp Allergy 2005; 35:1557-1564.
50. Sistek D, Kelly R, Wickens K, et al. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin Exp Allergy 2006; 36: 629-633.
51. Passeron T, Lacour JP, Fontas E, Ortonne JP. Prebiotics and synbiotics: two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 2006; 61:431-437.
52. Kukkonen K, Savilahti E, Haatela T, et al. Probiotics and prebiotic galactooligosaccharides in the prevention of allergic diseases: a randomized, doubleblind, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:192-198.
53. Abrahamsson TR, Jakobsson T, Bottcher MF, et al. Probiotics in prevention of IgE-associated eczema: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2007; 119:1174-1180.
54. Brouwer ML, Wolf-Plompen SA, Dubois AE, et al. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy 2006; 36:899-906.
55. Fölster-Holst R, Müller F, Schnopp N, et al. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol 2006; 155:1256-1261.
56. Taylor AL, Dunstan JA, Prescott SL. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increase the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007; 119:184-191.
57. Osborne DA, Sinn JK. Probiotics in infants for prevention of allergic disease and food hypersensitivity. Cochrane Database Syst Rev 2007:CD006475.
58. Mack DR, Ahrne S, Hyde L, et al. Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003; 52:827-833.
59. Caballero-Franco C, Keller K, De Simone C, Chadee K. The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic cells. Am J Physiol Gastrointest Liver Physiol 2007; 292:G315-G322.
60. Tao Y, Drabick KA, Waypa TS, et al. Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2006; 290:C1018-C1030.